Clinical Focus ›› 2022, Vol. 37 ›› Issue (6): 525-529.doi: 10.3969/j.issn.1004-583X.2022.06.008
Previous Articles Next Articles
Luo Weigang, Yin Yuanyuan, Ren Huiling()
Received:
2022-05-25
Online:
2022-06-20
Published:
2022-08-05
Contact:
Ren Huiling
E-mail:renhuiling2010@163.com
CLC Number:
Luo Weigang, Yin Yuanyuan, Ren Huiling. Analysis and treatment of primary spinal infection[J]. Clinical Focus, 2022, 37(6): 525-529.
Add to citation manager EndNote|Ris|BibTeX
URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2022.06.008
临床资料 | PSI组(n=32) | TSI组(n=28) | BSI组(n=19) | 统计值 | P值 |
---|---|---|---|---|---|
年龄[岁,M(Q1, Q3)] | 63.5(52.3, 70.5) | 61.0(37.3, 64.8) | 62.0(48.0, 66.0) | H=3.494 | 0.174 |
性别[例(%)] | |||||
男 女 | 17(53.1) 15(46.9) | 17(60.7) 11(39.3) | 12(63.2) 7(36.8) | χ2=0.604 | 0.739 |
起病时间[个月, M(Q1, Q3)] | 1.0(0.7, 3.0) | 5.0(1.3, 9.0)* | 2.0(1.0, 4.0) | H=8.900 | 0.012 |
临床症状[例(%)] | |||||
颈或背部疼痛 | 27(84.4) | 24(85.7) | 18(94.7) | χ2=1.179 | 0.629 |
发热或寒颤 | 23(71.9) | 7(25.0)* | 9(47.4) | χ2=13.167 | 0.001 |
神经功能障碍 | 15(46.9) | 12(42.9) | 11(57.9) | χ2=1.058 | 0.589 |
临床资料 | PSI组(n=32) | TSI组(n=28) | BSI组(n=19) | 统计值 | P值 |
---|---|---|---|---|---|
年龄[岁,M(Q1, Q3)] | 63.5(52.3, 70.5) | 61.0(37.3, 64.8) | 62.0(48.0, 66.0) | H=3.494 | 0.174 |
性别[例(%)] | |||||
男 女 | 17(53.1) 15(46.9) | 17(60.7) 11(39.3) | 12(63.2) 7(36.8) | χ2=0.604 | 0.739 |
起病时间[个月, M(Q1, Q3)] | 1.0(0.7, 3.0) | 5.0(1.3, 9.0)* | 2.0(1.0, 4.0) | H=8.900 | 0.012 |
临床症状[例(%)] | |||||
颈或背部疼痛 | 27(84.4) | 24(85.7) | 18(94.7) | χ2=1.179 | 0.629 |
发热或寒颤 | 23(71.9) | 7(25.0)* | 9(47.4) | χ2=13.167 | 0.001 |
神经功能障碍 | 15(46.9) | 12(42.9) | 11(57.9) | χ2=1.058 | 0.589 |
入院时炎性反应指标 | PSI组(n=32例) | TSI组(n=28) | BSI组(n=19) | H值 | P值 |
---|---|---|---|---|---|
WBC计数(×109/L) | 10.3(6.6, 15.3) | 7.30(5.7, 8.6) | 5.2(4.3, 7.4)* | 16.229 | 0.001 |
中性粒细胞百分比(%) | 77.8(69.1, 83.7) | 69.5(57.9, 74.8)* | 58.3(45.5, 65.5)* | 22.688 | 0.000 |
ESR(mm/1h) | 70.0(47.0, 94.0) | 33.0(16.0, 75.0)* | 47.0(18.0, 68.0) | 8.498 | 0.014 |
CRP(mg/L) | 89.3(44.4, 148.0) | 26.2(8.1, 43.1)* | 24.0(9.4, 79.3)* | 15.197 | 0.001 |
PCT(ng/ml) | 0.17(0.53, 1.18) | 0.04(0.04, 0.04)* | 0.04(0.04, 0.06)* | 19.343 | 0.000 |
入院时炎性反应指标 | PSI组(n=32例) | TSI组(n=28) | BSI组(n=19) | H值 | P值 |
---|---|---|---|---|---|
WBC计数(×109/L) | 10.3(6.6, 15.3) | 7.30(5.7, 8.6) | 5.2(4.3, 7.4)* | 16.229 | 0.001 |
中性粒细胞百分比(%) | 77.8(69.1, 83.7) | 69.5(57.9, 74.8)* | 58.3(45.5, 65.5)* | 22.688 | 0.000 |
ESR(mm/1h) | 70.0(47.0, 94.0) | 33.0(16.0, 75.0)* | 47.0(18.0, 68.0) | 8.498 | 0.014 |
CRP(mg/L) | 89.3(44.4, 148.0) | 26.2(8.1, 43.1)* | 24.0(9.4, 79.3)* | 15.197 | 0.001 |
PCT(ng/ml) | 0.17(0.53, 1.18) | 0.04(0.04, 0.04)* | 0.04(0.04, 0.06)* | 19.343 | 0.000 |
影像表现 | PSI组(n=32例) | TSI组(n=28) | BSI组(n=19) | χ2值 | P值 |
---|---|---|---|---|---|
病变部位[例(%)] | |||||
颈胸椎 腰骶椎 | 4(12.5) 28(87.5) | 12(42.9)* 16(57.1)* | 3(15.8) 16(84.2) | 8.469 | 0.014 |
受累椎体数量[个(%)] | |||||
1~2 ≥3 | 25(78.1) 7(21.9) | 17(60.7) 11(39.3) | 15(79.8) 4(21.2) | 2.828 | 0.243 |
椎间隙狭窄[例(%)] | 13(40.6) | 16(57.1) | 9(50.0) | 1.646 | 0.439 |
骨桥形成[例(%)] | 0 | 1(3.6) | 0 | 1.781 | 0.590 |
后凸畸形[例(%)] | 0 | 4(14.3) | 0 | 5.526 | 0.016 |
椎旁或腰大肌脓肿[例(%)] | 11(34.4) | 19(67.9)* | 3(16.7)# | 13.162 | 0.001 |
硬膜外脓肿[例(%)] | 9(28.1) | 4(14.3) | 2(11.1) | 2.835 | 0.242 |
影像表现 | PSI组(n=32例) | TSI组(n=28) | BSI组(n=19) | χ2值 | P值 |
---|---|---|---|---|---|
病变部位[例(%)] | |||||
颈胸椎 腰骶椎 | 4(12.5) 28(87.5) | 12(42.9)* 16(57.1)* | 3(15.8) 16(84.2) | 8.469 | 0.014 |
受累椎体数量[个(%)] | |||||
1~2 ≥3 | 25(78.1) 7(21.9) | 17(60.7) 11(39.3) | 15(79.8) 4(21.2) | 2.828 | 0.243 |
椎间隙狭窄[例(%)] | 13(40.6) | 16(57.1) | 9(50.0) | 1.646 | 0.439 |
骨桥形成[例(%)] | 0 | 1(3.6) | 0 | 1.781 | 0.590 |
后凸畸形[例(%)] | 0 | 4(14.3) | 0 | 5.526 | 0.016 |
椎旁或腰大肌脓肿[例(%)] | 11(34.4) | 19(67.9)* | 3(16.7)# | 13.162 | 0.001 |
硬膜外脓肿[例(%)] | 9(28.1) | 4(14.3) | 2(11.1) | 2.835 | 0.242 |
[1] |
Kourbeti IS, Tsiodras S, Boumpas DT. Spinal infections: evolving concepts[J]. Curr Opin Rheumatol, 2008, 20(4):471-479.
doi: 10.1097/BOR.0b013e3282ff5e66 pmid: 18525363 |
[2] |
Weissman S, Parker RD, Siddiqui W, et al. Vertebral osteomyelitis: retrospective review of 11 years of experience[J]. Scand J Infect Dis, 2014, 46(3):193-199.
doi: 10.3109/00365548.2013.868600 pmid: 24450841 |
[3] |
Duarte RM, Vaccaro AR. Spinal infection: state of the art and management algorithm[J]. Eur Spine J, 2013, 22(12):2787-2799.
doi: 10.1007/s00586-013-2850-1 pmid: 23756630 |
[4] |
Sato K, Yamada K, Yokosuka K, et al. Pyogenic spondylitis: clinical features, diagnosis and treatment[J]. Kurume Med J, 2019, 65(3):83-89.
doi: 10.2739/kurumemedj.MS653001 URL |
[5] |
Babic M, Simpfendorfer CS. Infections of the spine[J]. Infect Dis Clin North Am, 2017, 31(2):279-297.
doi: 10.1016/j.idc.2017.01.003 URL |
[6] | Herren C, Jung N, Pishnamaz M, et al. Spondylodiscitis: diagnosis and treatment options[J]. Dtsch Arztebl Int, 2017, 114(51-52):875-882. |
[7] |
Khanna K, Sabharwal S. Spinal tuberculosis: a comprehensive review for the modern spine surgeon[J]. Spine J, 2019, 19(11):1858-1870.
doi: 10.1016/j.spinee.2019.05.002 URL |
[8] |
Tali ET, Koc AM, Oner AY. Spinal brucellosis[J]. Neuroimaging Clin N Am, 2015, 25(2):233-245.
doi: 10.1016/j.nic.2015.01.004 URL |
[9] |
Yoon YK, Jo YM, Kwon HH, et al. Differential diagnosis between tuberculous spondylodiscitis and pyogenic spontaneous spondylodiscitis: a multicenter descriptive and comparative study[J]. Spine J, 2015, 15(8):1764-1771.
doi: 10.1016/j.spinee.2015.04.006 URL |
[10] | Marathe NA, Tedesco G, Chiesa AM, et al. Pyogenic and non-pyogenic spinal infections: diagnosis and treatment[J]. Curr Med Imaging, 2022, 18(2):231-241. |
[11] |
Lee KY. Comparison of pyogenic spondylitis and tuberculous spondylitis[J]. Asian Spine J, 2014, 8(2):216-223.
doi: 10.4184/asj.2014.8.2.216 URL |
[12] |
Yusuf M, Finucane L, Selfe J. Red flags for the early detection of spinal infection in back pain patients[J]. BMC Musculoskelet Disord, 2019, 20(1):606.
doi: 10.1186/s12891-019-2949-6 URL |
[13] |
Lazzeri E, Bozzao A, Cataldo MA, et al. Joint eanm/esnr and escmid-endorsed consensus document for the diagnosis of spine infection (spondylodiscitis) in adults[J]. Eur J Nucl Med Mol Imaging, 2019, 46(12):2464-2487.
doi: 10.1007/s00259-019-04393-6 URL |
[14] | Waheed G, Soliman M, Ali AM, et al. Spontaneous spondylodiscitis: review, incidence, management, and clinical outcome in 44 patients[J]. Neurosurg Focus, 2019, 46(1):E10. |
[15] |
Mylona E, Samarkos M, Kakalou E, et al. Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics[J]. Semin Arthritis Rheum, 2009, 39(1):10-17.
doi: 10.1016/j.semarthrit.2008.03.002 URL |
[16] |
Shakir R. Brucellosis[J]. J Neurol Sci, 2021, 420:117280.
doi: 10.1016/j.jns.2020.117280 URL |
[17] | Zheng R, Xie S, Lu X, et al. A systematic review and meta-analysis of epidemiology and clinical manifestations of human brucellosis in china[J]. Biomed Res Int, 2018, 2018:5712920. |
[18] |
Lee Y, Kim BJ, Kim SH, et al. Comparative analysis of spontaneous infectious spondylitis : pyogenic versus tuberculous[J]. J Korean Neurosurg Soc, 2018, 61(1):81-88.
doi: 10.3340/jkns.2016.1212.005 URL |
[19] |
Bornemann R, Rossler P, Jacobs C, et al. Spondylitis-spondylodiscitis-an update[J]. Z Orthop Unfall, 2019, 157(2):132-143.
doi: 10.1055/a-0641-6894 pmid: 30053761 |
[20] |
Boody BS, Tarazona DA, Vaccaro AR. Evaluation and management of pyogenic and tubercular spine infections[J]. Curr Rev Musculoskelet Med, 2018, 11(4):643-652.
doi: 10.1007/s12178-018-9523-y URL |
[21] |
Bozgeyik Z, Ozdemir H, Demirdag K, et al. Clinical and mri findings of brucellar spondylodiscitis[J]. Eur J Radiol, 2008, 67(1):153-158.
pmid: 17706906 |
[22] |
Raghavan M, Lazzeri E, Palestro CJ. Imaging of spondylodiscitis[J]. Semin Nucl Med, 2018, 48(2):131-147.
doi: S0001-2998(17)30107-1 pmid: 29452617 |
[23] |
Frel M, Bialecki J, Wieczorek J, et al. Magnetic resonance imaging in differentatial diagnosis of pyogenic spondylodiscitis and tuberculous spondylodiscitis[J]. Pol J Radiol, 2017, 82:71-87.
doi: 10.12659/PJR.899606 URL |
[24] |
Hong SH, Choi JY, Lee JW, et al. Mr imaging assessment of the spine: infection or an imitation?[J]. Radiographics, 2009, 29(2):599-612.
doi: 10.1148/rg.292085137 URL |
[25] |
Garg RK, Somvanshi DS. Spinal tuberculosis: a review[J]. J Spinal Cord Med, 2011, 34(5):440-454.
doi: 10.1179/2045772311Y.0000000023 URL |
[26] |
Na P, Mingzhi Y, Yin X, et al. Surgical management for lumbar brucella spondylitis: posterior versus anterior approaches[J]. Medicine (Baltimore), 2021, 100(21):e26076.
doi: 10.1097/MD.0000000000026076 URL |
[27] |
Guo H, Lan S, He Y, et al. Differentiating brucella spondylitis from tuberculous spondylitis by the conventional mri and mr t2 mapping: a prospective study[J]. Eur J Med Res, 2021, 26(1):125.
doi: 10.1186/s40001-021-00598-4 URL |
[28] | Berbari EF, Kanj SS, Kowalski TJ, et al. 2015 infectious diseases society of america (idsa) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults[J]. Clin Infect Dis, 2015, 61(6):e26-e46. |
[29] | Companion handbook to the who guidelines for the programmatic management of drug-resistant tuberculosis[M]. Geneva: World Health Organization, 2014. |
[30] |
Liang C, Wei W, Liang X, et al. Spinal brucellosis in hulunbuir, china, 2011-2016[J]. Infect Drug Resist, 2019, 12:1565-1571.
doi: 10.2147/IDR.S202440 pmid: 31239732 |
[1] | . [J]. Clinical Focus, 2023, 38(11): 1031-1033. |
[2] | . [J]. Clinical Focus, 2022, 37(12): 1137-1141. |
[3] | Lin Xiaoxia, Ke Zhongling, Chen Yanhui, Chen Hui, Chen Xianrui. Meta analysis of the relationship between vitamin D levels and tic disorder [J]. Clinical Focus, 2020, 35(12): 1061-1066. |
[4] | . [J]. CLINICAL FOCUS, 2008, 23(14): 1018-1018. |
[5] | . [J]. CLINICAL FOCUS, 2002, 17(8): 449-450. |
[6] | . [J]. CLINICAL FOCUS, 2002, 17(5): 276-277. |
[7] | . [J]. CLINICAL FOCUS, 2002, 17(2): 107-108. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||